QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
GE   79.81 (-0.15%)
F   16.32 (+0.87%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
NASDAQ:AEMD

Aethlon Medical - AEMD Stock Forecast, Price & News

$1.34
-0.02 (-1.47%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.26
$1.37
50-Day Range
$0.94
$1.99
52-Week Range
$0.88
$5.99
Volume
1.88 million shs
Average Volume
1.86 million shs
Market Capitalization
$22.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Aethlon Medical MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
198.5% Upside
$4.00 Price Target
Short Interest
Healthy
0.78% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.26mentions of Aethlon Medical in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.67 out of 5 stars

Medical Sector

1009th out of 1,125 stocks

Surgical & Medical Instruments Industry

96th out of 113 stocks

AEMD stock logo

About Aethlon Medical (NASDAQ:AEMD) Stock

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

Aethlon Medical Price Performance

NASDAQ:AEMD opened at $1.36 on Monday. The business's 50-day moving average price is $1.15 and its 200 day moving average price is $1.25. Aethlon Medical has a 52-week low of $0.88 and a 52-week high of $5.99.

Aethlon Medical (NASDAQ:AEMD - Get Rating) last announced its earnings results on Tuesday, June 28th. The medical equipment provider reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.13). Aethlon Medical had a negative net margin of 3,542.86% and a negative return on equity of 59.57%. The company had revenue of $0.01 million during the quarter, compared to analysts' expectations of $1.02 million. On average, equities analysts forecast that Aethlon Medical will post 0.78 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Aethlon Medical to a "sell" rating in a research report on Friday.

Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Stock News Headlines

Aethlon Medical (AEMD) to Release Quarterly Earnings on Tuesday
Aethlon Medical Q4 2022 Earnings Preview
Earnings Outlook For Aethlon Medical
/C O R R E C T I O N -- Aethlon Medical, Inc./
Aethlon Medical's Earnings Outlook
Aethlon Medical Q3 2022 Earnings Preview
See More Headlines
Receive AEMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aethlon Medical and its competitors with MarketBeat's FREE daily newsletter.

AEMD Company Calendar

Last Earnings
6/28/2022
Today
8/15/2022
Next Earnings (Estimated)
11/08/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AEMD
Fax
N/A
Employees
10
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$4.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+198.5%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-10,420,000.00
Net Margins
-3,542.86%
Pretax Margin
-6,931.48%

Debt

Sales & Book Value

Annual Sales
$290,000.00
Book Value
$1.10 per share

Miscellaneous

Free Float
16,106,000
Market Cap
$22.29 million
Optionable
Not Optionable
Beta
0.77

Key Executives

  • Dr. Charles J. Fisher Jr. (Age 75)
    M.D., CEO, Director & Member of Extracorporeal Therapy Advisory Board
    Comp: $509.14k
  • Mr. James B. Frakes M.B.A. (Age 65)
    CFO, Sr. VP of Fin. & Sec.
    Comp: $385k
  • Mr. Steven P. Larosa M.D.
    Chief Medical Officer & Acting Chief Scientific Officer
  • Mr. Guy F. Cipriani BS (Eng.) (Age 52)
    MBA, Sr. VP, Chief Bus. Officer & Director
    Comp: $29.75k
  • Mr. Sunil Sawhney
    Head of Clinical Studies
  • Dr. Richard H. Tullis Ph.D. (Age 77)
    Consultant













AEMD Stock - Frequently Asked Questions

What is Aethlon Medical's stock price forecast for 2022?

0 brokers have issued 12-month price targets for Aethlon Medical's stock. Their AEMD share price forecasts range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 198.5% from the stock's current price.
View analysts price targets for AEMD
or view top-rated stocks among Wall Street analysts.

How have AEMD shares performed in 2022?

Aethlon Medical's stock was trading at $1.86 on January 1st, 2022. Since then, AEMD stock has decreased by 28.0% and is now trading at $1.34.
View the best growth stocks for 2022 here
.

When is Aethlon Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 8th 2022.
View our AEMD earnings forecast
.

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) issued its quarterly earnings results on Tuesday, June, 28th. The medical equipment provider reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.13. The medical equipment provider had revenue of $0.01 million for the quarter, compared to analyst estimates of $1.02 million. Aethlon Medical had a negative trailing twelve-month return on equity of 59.57% and a negative net margin of 3,542.86%.

What other stocks do shareholders of Aethlon Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aethlon Medical investors own include Amarin (AMRN), Nokia Oyj (NOK), Vaxart (VXRT), VBI Vaccines (VBIV), Nabriva Therapeutics (NBRV), CRISPR Therapeutics (CRSP), Novavax (NVAX), OrganiGram (OGI), AT&T (T) and Aurora Cannabis (ACB).

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Natixis (0.15%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Aethlon Medical?

Shares of AEMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.34.

How much money does Aethlon Medical make?

Aethlon Medical (NASDAQ:AEMD) has a market capitalization of $22.29 million and generates $290,000.00 in revenue each year. The medical equipment provider earns $-10,420,000.00 in net income (profit) each year or ($0.73) on an earnings per share basis.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The official website for the company is www.aethlonmedical.com. The medical equipment provider can be reached via phone at (858) 459-7800 or via email at susan@sanoonan.com.

This page (NASDAQ:AEMD) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.